A case of chronic paclitaxel administration in ovarian cancer

Author： von Gruenigen V.E.   Karlen J.R.   Waggoner S.E.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.89, Iss.3, 2003-06, pp. : 532-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Rapidly Growing Ovarian Squamous Cell Carcinoma Successfully Controlled by Weekly Paclitaxel-Carboplatin Administration

By Ohtani K.   Sakamoto H.   Masaoka N.   Shimada K.   Kanaeda T.   Kurihara M.   Nagai N.   Satoh K.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 515-518

Elsevier

Access to resources Recommend Favorite

Hypersensitivity Reactions to Intraperitoneal Administration of Carboplatin in Ovarian Cancer: The First Report of a Case

By Shukunami K.-i.   Kurokawa T.   Kawakami Y.   Kubo M.   Kotsuji F.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 431-432

Elsevier

Access to resources Recommend Favorite

Chronic Administration of Single-Agent Paclitaxel in Gynecologic Malignancies

By Rohl J.   Kushner D.   Markman M.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 201-205

Elsevier

Access to resources Recommend Favorite

Second-Line Therapy of Ovarian Cancer with Paclitaxel Administered by Both the Intravenous and Intraperitoneal Routes: Rationale and Case Reports

By Markman M.   Kulp B.   Peterson G.   Kennedy A.   Belinson J.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 95-98

Academic Press

Access to resources Recommend Favorite

Topotecan in Platinum- and Paclitaxel-Resistant Ovarian Cancer

By Swisher E.M.   Mutch D.G.   Rader J.S.   Elbendary A.   Herzog T.J.  

Gynecologic Oncology, Vol. 66, Iss. 3, 1997-09 ,pp. : 480-486

Elsevier

Access to resources Recommend Favorite